Work

Abstract 10855: Cardiovascular Effectiveness of Empagliflozin Compared to Glucagon Like Peptide-1 Receptor Agonists and to Dipeptidyl Peptidase-4 Inhibitors in Older Patients: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study

Year: 2021

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.144.suppl_1.10855

Authors: Phyo Htoo, Julie Paik, Helen Tesfaye, Sebastian Schneeweiss, Dureshahwar Jawaid, Deborah Wexler, Robert Glynn, Lisette Koeneman, Anouk Deruaz Luyet, Mehdi Najafzadeh, Elisabetta Patorno

Institutions: Brigham and Women's Hospital, Massachusetts General Hospital, Harvard University

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3214794999

Cites:

Cited by:

Related to: 10